← Open Payments lookup

ANDREW SMEJDIR: Open Payments

NPI 1891459483 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 25 payments from 12 companies in 2025. Trend: 2023 $1,283 · 2024 $1,257 · 2025 $541

Food & beverage: $448Education: $93
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.11$233
Takeda Pharmaceuticals U.S.A., Inc.3$74
Grifols USA, LLC2$37
Amgen Inc.1$34
ARS Pharmaceuticals Operations, Inc.1$27
AstraZeneca Pharmaceuticals LP1$25
GlaxoSmithKline, LLC.1$21
Genentech USA, Inc.1$20
Lilly USA, LLC1$20
Octapharma USA, Inc.1$17

Products named: DUPIXENT, CUVITRU, NEFFY, TAKHZYRO, TEZSPIRE, TRELEGY ELLIPTA, Xolair, Xembify.

Industry payments across TX — which companies pay providers there.